This phase II/IIII trial studies how well haloperidol and lorazepam work in controlling
symptoms of persistent agitated delirium in patients with cancer that has spread to other
places in the body undergoing palliative care. Haloperidol and lorazepam may help in
controlling symptoms of agitated delirium in patients with cancer and may lessen any distress
that their caregivers may be experiencing.
Intervention
Haloperidol, Lorazepam, Placebo, Quality-of-Life Assessment, Questionnaire Administration
Condition
Delirium, Locally Advanced Malignant Neoplasm, Metastatic Malignant Neoplasm, Recurrent Malignant Neoplasm
Investigators
David Hui, Egidio Del Fabbro, Carlos E. Paiva